Armata Pharmaceuticals Inc. (ARMP) – Trading Performance Overview
- Stock Price (as of 11:34 PM CET, Friday 23 Oct 2026): USD 3.64
- 24‑hour price change: +12.75 %
- Shares outstanding: 37.2 million
- Market capitalization: USD 113.8 million
- Trading volume (last 24 h): USD 372.3 k
- Month‑end performance (last month): –5.22 %
- 200‑day simple moving average: USD 7.11
- 52‑week high: USD 14.98 (22 April 2026)
- 52‑week low: USD 2.75 (14 October 2026)
Comparative Performance – 24‑hour Summary
| Ticker | 24‑h price change | Current price (USD) | Market cap (USD) | P/E ratio* |
|---|---|---|---|---|
| ANTX – An2 Therapeutics | +1.12 % | 3.55 | 135.9 m | – |
| PLBY – Playboy | 0 % | 1.09 | 135.4 m | 340.36 |
| SRBK – Sr | –0.59 % | 18.88 | 135.9 m | 43.64 |
| HOFT – Hooker Furnishings | +0.16 % | 12.78 | 136.3 m | – |
| MED – Medifast | +0.58 % | 11.87 | 135.3 m | – |
*Price‑to‑earnings ratio provided only for PLBY and SRBK.
Company Background
Armata Pharmaceuticals, Inc. is headquartered in Marina Del Rey, California. The company focuses on clinical‑stage development of bacteriophage‑based therapies aimed at treating multidrug‑resistant bacterial infections and preventing infectious diseases related to the microbiome. Its research and development activities target patients within California, with an objective to influence the broader healthcare sector.
End of article
